CD22 and lymphoma: For example, Huang et al. coupled CD22 ligands onto NK cells to generate modified NK cells with tumor-targeting capabilities.234 These NK cells displayed high selectivity and cytotoxicity to CD22+ lymphoma cells in a CD22-dependent manner, which had a considerable protective effect in tumor-bearing mice.